FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078628061> ?p ?o ?g. }

• W2078628061 endingPage "1357" @default.
• W2078628061 startingPage "1349" @default.
• W2078628061 abstract "The efficacy of nucleoside(tide) analogues (NA) in the treatment of acute liver failure due to hepatitis B virus (HBV-ALF) remains controversial. We determined retrospectively the impact of NAs in a large cohort of patients with HBV-ALF. The US Acute Liver Failure Study Group, a 23-site registry, prospectively enrolled 1,413 patients with ALF with different etiologies between 1998 and 2008. Of those, 105 patients were identified as HBV-ALF patients, of whom we excluded those without data on NA use or with co-infection with hepatitis C, leaving 85 patients, 43 of whom had received NA treatment. HBV-DNA on admission was quantified by real time polymerase chain reaction. The treated and untreated groups were similar in most respects but differed significantly in regard to higher aminotransferase and bilirubin levels and hepatic coma grades, all being observed in the untreated group. Median duration of NA treatment was 6 days (range, 1–21 days). Overall survival in the NA treated and untreated groups were 61 and 64%, respectively (P = 0.72). Rates of transplant-free survival were 21 and 36% in the treated and untreated groups, respectively (P = 0.42). Multivariate analysis revealed that not using a NA [odds ratio (OR) 4.4, 95% CI 1.1–18.1, P = 0.041], hepatic coma grade I or II [OR 14.4, 95% CI 3.3–62.8, P < 0.001] and prothrombin time (PT) [OR 0.59, 95% CI 0.39–0.89, P = 0.012] were predictors of improved transplant-free survival. Patients who are admitted with established HBV-ALF do not appear to benefit from viral suppression using nucleoside(tide) analogues presumably because of rapid disease evolution and short treatment duration. Despite the lack of benefit, NAs should still be given to transplantation candidates since viral suppression prevents recurrence after grafting." @default.
• W2078628061 created "2016-06-24" @default.
• W2078628061 creator A5004071716 @default.
• W2078628061 creator A5019927380 @default.
• W2078628061 creator A5028383260 @default.
• W2078628061 creator A5047313225 @default.
• W2078628061 creator A5057305719 @default.
• W2078628061 creator A5070467866 @default.
• W2078628061 date "2011-12-25" @default.
• W2078628061 modified "2023-10-14" @default.
• W2078628061 title "Use of Nucleoside (Tide) Analogues in Patients with Hepatitis B-Related Acute Liver Failure" @default.
• W2078628061 cites W1964520444 @default.
• W2078628061 cites W1964966497 @default.
• W2078628061 cites W1983450627 @default.
• W2078628061 cites W1996736510 @default.
• W2078628061 cites W2022001600 @default.
• W2078628061 cites W2029691647 @default.
• W2078628061 cites W2031317669 @default.
• W2078628061 cites W2038485468 @default.
• W2078628061 cites W2068920446 @default.
• W2078628061 cites W2080805631 @default.
• W2078628061 cites W2101159020 @default.
• W2078628061 cites W2138529156 @default.
• W2078628061 cites W2153279772 @default.
• W2078628061 cites W2157305642 @default.
• W2078628061 cites W2158736090 @default.
• W2078628061 cites W2159101750 @default.
• W2078628061 cites W2164439917 @default.
• W2078628061 cites W2169773083 @default.
• W2078628061 cites W2323719395 @default.
• W2078628061 cites W2327877747 @default.
• W2078628061 cites W3149450293 @default.
• W2078628061 cites W3152231134 @default.
• W2078628061 cites W4233520648 @default.
• W2078628061 cites W4362208329 @default.
• W2078628061 doi "https://doi.org/10.1007/s10620-011-2013-3" @default.
• W2078628061 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3565239" @default.
• W2078628061 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22198704" @default.
• W2078628061 hasPublicationYear "2011" @default.
• W2078628061 type Work @default.
• W2078628061 sameAs 2078628061 @default.
• W2078628061 citedByCount "33" @default.
• W2078628061 countsByYear W20786280612013 @default.
• W2078628061 countsByYear W20786280612014 @default.
• W2078628061 countsByYear W20786280612015 @default.
• W2078628061 countsByYear W20786280612016 @default.
• W2078628061 countsByYear W20786280612017 @default.
• W2078628061 countsByYear W20786280612018 @default.
• W2078628061 countsByYear W20786280612019 @default.
• W2078628061 countsByYear W20786280612020 @default.
• W2078628061 countsByYear W20786280612021 @default.
• W2078628061 countsByYear W20786280612022 @default.
• W2078628061 countsByYear W20786280612023 @default.
• W2078628061 crossrefType "journal-article" @default.
• W2078628061 hasAuthorship W2078628061A5004071716 @default.
• W2078628061 hasAuthorship W2078628061A5019927380 @default.
• W2078628061 hasAuthorship W2078628061A5028383260 @default.
• W2078628061 hasAuthorship W2078628061A5047313225 @default.
• W2078628061 hasAuthorship W2078628061A5057305719 @default.
• W2078628061 hasAuthorship W2078628061A5070467866 @default.
• W2078628061 hasBestOaLocation W20786280612 @default.
• W2078628061 hasConcept C126322002 @default.
• W2078628061 hasConcept C141071460 @default.
• W2078628061 hasConcept C156957248 @default.
• W2078628061 hasConcept C203014093 @default.
• W2078628061 hasConcept C2522874641 @default.
• W2078628061 hasConcept C2777382497 @default.
• W2078628061 hasConcept C2777513400 @default.
• W2078628061 hasConcept C2780434524 @default.
• W2078628061 hasConcept C2780593183 @default.
• W2078628061 hasConcept C41260117 @default.
• W2078628061 hasConcept C71924100 @default.
• W2078628061 hasConcept C90924648 @default.
• W2078628061 hasConceptScore W2078628061C126322002 @default.
• W2078628061 hasConceptScore W2078628061C141071460 @default.
• W2078628061 hasConceptScore W2078628061C156957248 @default.
• W2078628061 hasConceptScore W2078628061C203014093 @default.
• W2078628061 hasConceptScore W2078628061C2522874641 @default.
• W2078628061 hasConceptScore W2078628061C2777382497 @default.
• W2078628061 hasConceptScore W2078628061C2777513400 @default.
• W2078628061 hasConceptScore W2078628061C2780434524 @default.
• W2078628061 hasConceptScore W2078628061C2780593183 @default.
• W2078628061 hasConceptScore W2078628061C41260117 @default.
• W2078628061 hasConceptScore W2078628061C71924100 @default.
• W2078628061 hasConceptScore W2078628061C90924648 @default.
• W2078628061 hasIssue "5" @default.
• W2078628061 hasLocation W20786280611 @default.
• W2078628061 hasLocation W20786280612 @default.
• W2078628061 hasLocation W20786280613 @default.
• W2078628061 hasLocation W20786280614 @default.
• W2078628061 hasOpenAccess W2078628061 @default.
• W2078628061 hasPrimaryLocation W20786280611 @default.
• W2078628061 hasRelatedWork W1984983189 @default.
• W2078628061 hasRelatedWork W2021403748 @default.
• W2078628061 hasRelatedWork W2038929933 @default.
• W2078628061 hasRelatedWork W2040973434 @default.
• W2078628061 hasRelatedWork W2062638930 @default.
• W2078628061 hasRelatedWork W2362454490 @default.

• next